BIOMAT Database Logo BIOMAT Database Logo

Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study. 2017

N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.

The opioid antagonist naltrexone has been shown to attenuate the subjective effects of amphetamine. However, the mechanisms behind this modulatory effect are currently unknown. We hypothesized that naltrexone would diminish the striatal dopamine release induced by amphetamine, which is considered an important mechanism behind many of its stimulant properties. We used positron emission tomography and the dopamine D2-receptor radioligand [11C]raclopride in healthy subjects to study the dopaminergic effects of an amphetamine injection after pretreatment with naltrexone or placebo. In a rat model, we used microdialysis to study the modulatory effects of naltrexone on dopamine levels after acute and chronic amphetamine exposure. In healthy humans, naltrexone attenuated the subjective effects of amphetamine, confirming our previous results. Amphetamine produced a significant reduction in striatal radioligand binding, indicating increased levels of endogenous dopamine. However, there was no statistically significant effect of naltrexone on dopamine release. The same pattern was observed in rats, where an acute injection of amphetamine caused a significant rise in striatal dopamine levels, with no effect of naltrexone pretreatment. However, in a chronic model, naltrexone significantly attenuated the dopamine release caused by reinstatement of amphetamine. Collectively, these data suggest that the opioid system becomes engaged during the more chronic phase of drug use, evidenced by the modulatory effect of naltrexone on dopamine release following chronic amphetamine administration. The importance of opioid-dopamine interactions in the reinforcing and addictive effects of amphetamine is highlighted by the present findings and may help to facilitate medication development in the field of stimulant dependence.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009271 Naltrexone Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence. Antaxone,Celupan,EN-1639A,Nalorex,Naltrexone Hydrochloride,Nemexin,ReVia,Trexan,EN 1639A,EN1639A
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D003342 Corpus Striatum Striped GRAY MATTER and WHITE MATTER consisting of the NEOSTRIATUM and paleostriatum (GLOBUS PALLIDUS). It is located in front of and lateral to the THALAMUS in each cerebral hemisphere. The gray substance is made up of the CAUDATE NUCLEUS and the lentiform nucleus (the latter consisting of the GLOBUS PALLIDUS and PUTAMEN). The WHITE MATTER is the INTERNAL CAPSULE. Lenticular Nucleus,Lentiform Nucleus,Lentiform Nuclei,Nucleus Lentiformis,Lentiformis, Nucleus,Nuclei, Lentiform,Nucleus, Lenticular,Nucleus, Lentiform,Striatum, Corpus
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000661 Amphetamine A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE. Desoxynorephedrin,Levoamphetamine,Phenopromin,l-Amphetamine,Amfetamine,Amphetamine Sulfate,Amphetamine Sulfate (2:1),Centramina,Fenamine,Mydrial,Phenamine,Thyramine,levo-Amphetamine,Sulfate, Amphetamine,l Amphetamine,levo Amphetamine

Related Publications

N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
Increased amphetamine potency following chronic naltrexone administration in rats.
October 1979, Life sciences,
N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
Extended-release naltrexone: good but not a panacea.
January 2018, Lancet (London, England),
N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
Protein phosphatases but not reactive oxygen species play functional role in acute amphetamine-mediated dopamine release.
July 2013, Cell biochemistry and biophysics,
N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
Exogenous, but not endogenous nociceptin modulates mesolimbic dopamine release in mice.
April 2004, Journal of neurochemistry,
N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
Chronic smoking, but not acute nicotine administration, modulates neural correlates of working memory.
January 2011, Psychopharmacology,
N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
PHACTR1 modulates vascular compliance but not endothelial function: a translational study.
March 2023, Cardiovascular research,
N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism.
August 1982, Life sciences,
N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
Environmental enrichment attenuates locomotor sensitization, but not in vitro dopamine release, induced by amphetamine.
January 1995, Pharmacology, biochemistry, and behavior,
N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
Cortical cholinergic deficiency enhances amphetamine-induced dopamine release in the accumbens but not striatum.
November 2007, Experimental neurology,
N Jayaram-Lindström, and J Guterstam, and J Häggkvist, and M Ericson, and T Malmlöf, and B Schilström, and C Halldin, and S Cervenka, and T Saijo, and A-L Nordström, and J Franck
Post-training, but not post-reactivation, administration of amphetamine and anisomycin modulates Pavlovian conditioned approach.
May 2007, Neurobiology of learning and memory,
Copied contents to your clipboard!